1,899
Views
42
CrossRef citations to date
0
Altmetric
Review Articles

Ureaplasma species and preterm birth: current perspectives

, , &
Pages 169-181 | Received 08 Jul 2019, Accepted 25 Feb 2020, Published online: 06 Mar 2020

References

  • Arfi Y, Minder L, Di Primo C, Le Roy A, Ebel C, Coquet L, Claverol S, Vashee S, Jores J, Blanchard A, et al. 2016. MIB-MIP is a mycoplasma system that captures and cleaves immunoglobulin G. Proc Natl Acad Sci USA. 113(19):5406–5411.
  • Bebear CM, Renaudin H, Charron A, Clerc M, Pereyre S, Bebear C. 2003. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones. Antimicrob Agents Chemother. 47(10):3323–3325.
  • Bebear CM, Renaudin H, Charron A, Gruson D, Lefrancois M, Bebear C. 2000. In vitro activity of trovafloxacin compared to those of five antimicrobials against Mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother. 44(9):2557–2560.
  • Beeton ML, Chalker VJ, Jones LC, Maxwell NC, Spiller OB. 2016. Antibiotic resistance among clinical Ureaplasma isolates recovered from neonates in England and Wales between 2007 and 2013. Antimicrob Agents Chemother. 60(1):52–56.
  • Beeton ML, Chalker VJ, Kotecha S, Spiller OB. 2009. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. J Antimicrob Chemother. 64(3):529–538.
  • Beeton ML, Spiller OB. 2017. Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? J Antimicrob Chemother. 72(2):330–337.
  • Bharat A, Cunningham SA, Scott Budinger GR, Kreisel D, DeWet CJ, Gelman AE, Waites K, Crabb D, Xiao L, Bhorade S, et al. 2015. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med. 7(284):284re3–284re3.
  • Biernat-Sudolska M, Rojek-Zakrzewska D, Lauterbach R. 2006. Assessment of various diagnostic methods of ureaplasma respiratory tract infections in newborns. Acta Biochim Pol. 53(3):609–611.
  • Blanchard A. 1990. Ureaplasma urealyticum urease genes; use of a UGA tryptophan codon. Mol Microbiol. 4(4):669–676.
  • Cao X, Wang Y, Hu X, Qing H, Wang H. 2007. Real-time Taqman polymerase chain reaction assays for quantitative detection and differentiation of Ureaplasma urealyticum and Ureaplasma parvum. Diagn Microbiol Infect Dis. 57(4):373–378.
  • Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. 1993. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev. 6(1):69–87.
  • Centers for Disease Control and Prevention (CDC). 2016. Preterm birth; [accessed 2020 Mar 02]. http://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm.
  • Chang-Tai Z, Zhong-Yi H, Chun-Lei D, Chang-Song Z, Meizhen W, Yang L. 2011. Investigation of Ureaplasma urealyticum biovars and their relationship with antimicrobial resistance. Indian J Med Microbiol. 29(3):288–292.
  • CLSI. 2011. Methods for antimicrobial susceptibility testing for human mycoplasmas; approved guideline. CLSI Document M43-A. Wayne (PA): Clinical and Laboratory Standards Institute
  • Cordova CMM, Blanchard A, Cunha R. 2000. Higher prevalence of urogenital mycoplasmas in Human Immunodeficiency virus – positive patients as compared to patients with other sexually transmitted diseases. J Clin Lab Anal. 14(5):246–253.
  • Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sánchez PJ, Ambalavanan N, Benjamin DK. Jr., for the NICHD Neonatal Research Network. 2009. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 123(1):58–66.
  • Crouse DT, English BK, Livingston L, Meals EA. 1998. Genital mycoplasmas stimulate tumor necrosis factor-alpha and inducible nitric oxide synthase production from a murine macrophage cell line. Pediatr Res. 44(5):785–790.
  • Crouse DT, Odrezin GT, Cutter GR, Reese JM, Hamrick WB, Waites KB, Cassell GH. 1993. Radiographic changes associated with tracheal isolation of Ureaplasma urealyticum from neonates. Clin Infect Dis. 17(Supplement_1):S122–S30.
  • Dando SJ, Nitsos I, Polglase GR, Newnham JP, Jobe AH, Knox CL. 2014. Ureaplasma parvum undergoes selection in utero resulting in genetically diverse isolates colonizing the chorioamnion of fetal sheep. Biol Reprod. 90(2):27.
  • de Goffau MC, Lager S, Sovio U, Gaccioli F, Cook E, Peacock SJ, Parkhill J, Charnock-Jones S, Smith G. 2019. Human placenta has no microbiome but can contain potential pathogens. Nature. 572(7769):329–334.
  • Degrange S, Renaudin H, Charron A, Bebear C, Bebear CM. 2008. Tetracycline resistance in Ureaplasma spp. and Mycoplasma hominis: prevalence in Bordeaux, France, from 1999 to 2002 and description of two tet(M)-positive isolates of M. hominis susceptible to tetracyclines. Antimicrob. Agents Chemother. 52(2):742–744.
  • Deguchi T, Yoshida T, Miyazawa T, Yasuda M, Tamaki M, Ishiko H, Maeda S-I. 2004. Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis. Sex Transm Dis. 31(3):192–195. DOI:10.1097/01.olq.0000114653.26951.71.
  • DeSilva NS, Quinn PA. 1999. Characterization of phospholipase A1, A2, C activity in Ureaplasma urealyticum membranes. Mol Cell Biochem. 201(1-2):159–167.
  • DiGiulio DB. 2012. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med. 17(1):2–11.
  • Duffy LB, Crabb D, Searcey K, Kempf MC. 2000. Comparative potency of gemifloxacin, new quinolones, tetracycline and clindamycin against Mycoplasma spp. J Antimicrob Chemother. 45(90003):29–33.
  • Duffy LB, Waites K. 2008. Mycoplasma techniques workshop manual, 17th International Organization for Mycoplasmology Congress. China: Tianjin Medical University.
  • Ghosh A, Rawre J, Khanna N, Dhawan B. 2013. Co-infections with Ureaplasma parvum, Mycoplasma hominis and Chlamydia trachomatis in a human immunodeficiency virus positive woman with vaginal discharge. Indian J Med Microbiol. 31(2):190–192.
  • Glaser K, Speer CP. 2015. Neonatal CNS infection and inflammation caused by Ureaplasma species: rare or relevant? Expert Rev. Anti Infect Ther. 13(2):233–248.
  • Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, Cassell GH. 2000. The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature. 407(6805):757–762.
  • Goldenberg RL, Hauth JC, Andrews WW. 2000. Intrauterine infection and preterm delivery. N Engl J Med. 342(20):1500–1507. DOI:10.1056/NEJM200005183422007.
  • Goldenberg RL, Andrews WW, Goepfert AR, Petersen OF, Cliver SP, Carlo WA, Hauth JC. 2008. The Alabama preterm birth study: Umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborns. Am J Obstet Gynecol. 198(1):43.e1–43.e5.
  • Govender S, Chalkley LJ. 2012. Tetracycline genes of Ureaplasmas. South Afr. J Epidemiol Infect. 27(1):19–23.
  • Govender S, Gqunta K, Le Roux M, de Villiers B, Chalkley LJ. 2012. Antibiotic susceptibilities and resistance genes of Ureaplasma parvum isolated in South Africa. J Antimicrob Chemother. 67(12):2821–2824.
  • Gupta A, Gupta A, Gupta S, Mittal A, Chandra P, Gill AK. 2009. Correlation of mycoplasma with unexplained infertility. Arch Gynecol Obstet. 280(6):981–985.
  • Gwee A, Curtis N. 2014. Ureaplasma – Are you sitting comfortably? Journal of Infection. 68:S19–S23.
  • Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M. 2018. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? – a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol. 32(11):1845–1851.
  • Ireland DJ, Keelan JA. 2014. The maternal serological response to intrauterine Ureaplasma sp. infection and prediction of risk of pre-term birth. Front Immunol. 5:624.
  • Jacobsson B, Mattsby-Baltzer I, Andersch B, Bokstrom H, Holst R-M, Nikolaitchouk N, Wennerholm U-B, Hagberg H. 2003. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with pre- term prelabor rupture of membranes. Acta Obstet Gynecol Scand. 82(5):423–431.
  • Kacerovsky M, Celec P, Vlkova B, Skogstrand K, Hougaard DM, Cobo T, Jacobsson B. 2013. Amniotic fluid protein profiles of intraamniotic inflammatory response to Ureaplasma spp. and other bacteria. PLoS One. 8(3):e60399.
  • Kacerovsky M, Musilova I, Khatibi A, Skogstrand K, Hougaard DM, Tambor V, Tosner J, Jacobsson B. 2012. Intraamniotic inflammatory response to bacteria: analysis of multiple amniotic fluid proteins in women with preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 25(10):2014–2019.
  • Kasper DC, Mechtler TP, Bohm J, Petricevic L, Gleiss A, Spergser J, Witt A, Herkner KR, Berger A. 2011. In utero exposure to Ureaplasma spp. is associated with increased rate of bronchopulmonary dysplasia and intraventricular hemorrhage in preterm infants. J Perinat Med. 39(3):331–336.
  • Kawai Y, Nakura Y, Wakimoto T, Nomiyama M, Tokuda T, Takayanagi T, Shiraishi J, Wasada K, Kitajima H, Fujita T, et al. 2015. In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan. Antimicrob Agents Chemother. 59(4):2358–2364.
  • Keelan JA, Payne MS, Kemp MW, Ireland DJ, Newnham JP. 2016. A new, potent, and placenta-permeable macrolide antibiotic, Solithromycin, for the prevention and treatment of bacterial infections in pregnancy. Front Immunol. 7:111
  • Kikhney J, von Schoning D, Steding I, Schulze J, Petrich A, Hiergeist A, Reischl U, Moter A, Thomas A. 2017. Is Ureaplasma spp. the leading causative agent of acute chorioamnionitis in women with preterm birth? Clinical Microbiology and Infection. 23(2):119.e1–119.e7.
  • Kim M, Kim G, Romero R, Shim S, Kim E, Yoon BH. 2003. Biovar Diversity of Ureaplasma urealyticum in amniotic fluid: distribution, intrauterine inflammatory response and pregnancy outcomes. J Perinat Med. 31(2):146–152.
  • Knox CL, Allan JA, Allan JM, Edirisinghe WR, Stenze DL, Lawrence FL, Purdie D, Timms P. 2003. Ureaplasma parvum and Ureaplasma urealyticum are detected in semen after washing before assisted reproductive technology procedures. Fertil Steril. 80(4):921e9–92929.
  • Kokkayil P, Dhawan B. 2015. Ureaplasma: current perspectives. Indian J Med Microbiol. 33:205–214.
  • Kong F, Gilbert GL. 2004. Postgenomic taxonomy of human Ureaplasmas – a case study based on multiple gene sequences. International J Syst Evolution Microbiol. 54(5):1815–1821.
  • Kong F, Ma Z, James G, Gordon S, Gilbert GL. 2000. Species identification and subtyping of Ureaplasma parvum and Ureaplasma urealyticum using PCR- based assays. J Clin Microbiol. 38(3):1175–1179.
  • Le Roux M, De Villiers BE, Ditsele MRM, Monokoane ST, Ngobeni LM. 2013. P3.299 tetracycline resistance in Ureaplasma species isolated from women presenting for termination of pregnancy pretoria, South Africa. Sex Transm Infect. 89:A242.
  • Leon LJ, Doyle R, Diez-Benavente E, Clark TG, Klein N, Stanier P, Moore GE. 2018. Enrichment of clinically relevant organisms in spontaneous preterm-delivered placentas and reagent contamination across all clinical groups in a large pregnancy cohort in the United Kingdom. Appl Environ Microbiol. 84(14):e0048318.
  • Li Y-H, Brauner A, Jonsson B, van der Ploeg I, Söder O, Holst M, Jensen JS, Lagercrantz H, Tullus K. 2000. Ureaplasma urealyticum induced production of proinflammatory cytokines by macrophages. Pediatr Res. 48(1):114–119.
  • Lu C, Ye T, Zhu G, Feng P, Ma H, Lu R, Lai W. 2010. Phenotypic and genetic characteristics of macrolide and lincosamide resistant Ureaplasma urealyticum isolated in Guangzhou, China. Curr Microbiol. 61(1):44–49.
  • Mallard K, Schopfer K, Bodmer T. 2005. Development of real-time PCR for the differential detection and quantification of Ureaplasma urealyticum and Ureaplasma parvum. J Microbiol Methods. 60(1):13–19.
  • Namba F, Hasegawa T, Nakayama M, Hamanaka T, Yamashita T, Nakahira K, Kimoto A, Nozaki M, Nishihara M, Mimura K, et al. 2010. Placental features of chorioamnionitis colonized with Ureaplasma species inpreterm delivery. Pediatr Res. 67(2):166–172. 2010
  • Nelson S, Matlow A, Johnson G, Th’ng C, Dunn M, Quinn P. 1998. Detection of Ureaplasma urealyticum in endotracheal tube aspirates from neonates by PCR. J Clin Microbiol. 36(5):1236–1239.
  • Ngobeni LM, de Villiers B, Le Roux M, Ditsele RMM, Monokoane S. 2014. Prevalence and antibiotic susceptibility of ureaplasma species isolated from women presenting for termination of pregnancy at the Doctor George Mukhari Academic Hospital. Int J Infect Dis. 21:87.
  • Novy MJ, Duffy L, Axthelm MK, Sadowsky DW, Witkin SS, Gravett MG, Cassell GH, Waites KB. 2009. Ureaplasma parvum or Mycoplasma homi- nis as sole pathogens cause Chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci. 16(1):56–70.
  • Olomu IN, Hecht JL, Onderdonk AO, Allred EN, Leviton A. Extremely Low Gestational Age Newborn Study Investigators. 2009. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation. Pediatrics. 123(5):1329–1336.
  • Ozdemýr R, Sarý FN, Tunay ZO, Erdeve O, Canpolat FE, Oguz SS. 2012. The association between respiratory tract Ureaplasma urealyticum colonization and severe retinopathy of prematurity in preterm infants < 1250 g. Eye. 26:992–996.
  • Pandelidis K, McCarthy A, Chesko KL, Viscardi RM. 2013. Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates. Pediatr Infect Dis J. 32(4):394–398.
  • Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Methé BA, Inman J, Yooseph S, Xiao L, Cassell GH, et al. 2012. Comparative genome-analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains. BMC Microbiol. 12(1):88.,
  • Pavlidis I, Spiller OB, Sammut Demarco G, MacPherson H, Howie S, Norman JE, Stock SJ. 2020. Cervical epithelial damage promotes Ureaplasma parvum ascending infection, intrauterine inflammation and preterm birth induction in mice. Nat Commun. 11(1):199.
  • Pereyre S, Gonzalez P, De Barbeyrac B, Darnige A, Renaudin H, Charron A, Raherison S, Bebear C, Bebear CM. 2002. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for resistance to macrolides in M. hominis. Antimicrob Agents Chemother. 46(10):3142–3150.
  • Pereyre S, Metifiot M, Cazanave C, Renaudin H, Charron A, Bebear C, Bebear CM. 2007. Characterization of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics. Int J Antimicrob Agents. 29(2):207–211.
  • Pinna GS, Skevaki CL, Kafetzis DA. 2006. The significance of Ureaplasma urealyticum as a pathogenic agent in the paediatric population. Curr Opin Infect Dis. 19(3):283–289.
  • Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. 2007. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta- analysis of randomised controlled trials. Int J Antimicrob Agents. 30(3):213–221.
  • Prince AL, Ma J, Kannan PS. 2016. The placental microbiome is altered among subjects with spontaneous preterm birth with and without Chorioamnionitis. Am J Obstet Gynecol. 214:627.1–16.
  • Redline RW. 2006. Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonat Med. 11(5):296–301.
  • Rittenschober-Böhm J, Waldhoer T, Schulz SM, Pimpel B, Goeral K, Kasper DC, Witt A, Berger A. 2019. Vaginal Ureaplasma parvum serovars and spontaneous preterm birth. Am J Obstet Gynecol. 220(6):594.e1–594.e9. 2019,
  • Robertson JA, Stemke GW, Davis JW, Harasawa R, Thirkell D, Kong F, Shepard MC, Ford DK. 2002. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol. 52(Pt 2):587–597. DOI:10.1099/00207713-52-2-587.
  • Robertson JA, Vekris A, Bebear C, Stemke GW. 1993. Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol. 31(4):824–830.
  • Schelonka RL, Waites KB. 2007. Ureaplasma infection and neonatal lung disease. Semin Perinatol. 31(1):2–9.
  • Senthamaraikannan P, Presicce P, Rueda CM, Maneenil G, Schmidt AF, Miller LA, Waites KB, Jobe AH, Kallapur SG, Chougnet CA. 2016. Intra- amniotic Ureaplasma parvum induced maternal and fetal inflammation and immune responses in rhesus macaque. J Infect Dis. 214(10):1597–1604.
  • Sung TJ. 2010. Ureaplasma infections in pre-term infants: recent information regarding the role of Ureaplasma species as neonatal pathogens. Korean J Pediatr. 53(12):989–993.
  • Sweeney EL, Dando SJ, Kallapur SG, Knox CL. 2017. The human Ureaplasma species as causative agents of chorioamnionitis. Clin Microbiol Rev. 30(1):349–379.
  • Sweeney EL, Suhas G, Kallapur SG, Gisslen T, Lambers DS, Chougnet CA, Stephenson S, Jobe AH, Knox CL. 2016. Placental infection with Ureaplasma species is associated with histologic chorioamnionitis and adverse outcomes in moderately preterm and late-preterm infants. J Infect Dis. 213(8):1340–1347.
  • Taylor-Robinson D. 1996. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis. 23(4):671–682.
  • Taylor-Robinson D. 2007. The role of mycoplasmas in pregnancy outcome. Best Practice Res Clin Obstet Gynaecol. 21(3):425–438.
  • Taylor-Robinson D, Bébéar C. 1997. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother. 40(5):622–630.
  • Triantafilou M, De Glanville B, Aboklaish AF, Spiller OB, Kotecha S, Triantafilou K. 2013. Synergic Activation of Toll-Like Receptor (TLR) 2/6 and 9 in Response to Ureaplasma parvum and Urealyticum in human amniotic epithelial cells. PLoS One. 8(4):e61199.
  • Tully JG, Taylor-Robinson D. 1986. Taxonomy and host distribution of the ureaplasmas. Pediatr Infect Dis. 5(Supplement):S292–S5.
  • Waites KB, Crabb DM, Duffy LB. 2009. Comparative in vitro susceptibilities of a new investigational ketolide CEM-101 against human Mycoplasmas and Ureaplasmas. Antimicrob Agents Chemother. 53(5):2139–2141.
  • Waites KB, Katz B, Schelonka RL. 2005. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev. 18(4):757–789.
  • Waites KB, Schelonka RL, Xiao L, Grigsby PL, Novy MJ. 2009. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonatal Med. 14(4):190–199.
  • Waites KB, Taylor-Robinson D. 2007. Mycoplasma and Ureaplasma. In: Murray PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller M, editors. Manual of clinical microbiology. 9th ed. Washington DC. ASM Press; p. 1004–1020.
  • Waites KB, Xiao L, Paralanov V, Viscardi RM, Glass JI. 2012. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont-Hospital Symposium on molecular pathology. J Mol Diagn. 14(5):437–450.
  • Watts DH, Krohn MA, Hillier SL, Eschen-Bach DA. 1992. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol. 79(3):351–357.
  • Witt A, Berger A, Gruber CJ, Petricevic L, Apfalter P, Worda C, Husslein P. 2005. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol. 193(5):1663–1669.
  • Wu HN, Nakura Y, Motooka D, Nakamura S, Nishiumi F, Ishino S, Kawai Y, Tanaka T, Takeuchi M, Nakayama M, et al. 2014. Complete genome sequence of Ureaplasma parvum serovar 3 strain SV3F4, isolated in Japan. Genome Announc. 2(3):e00256–14.
  • Xiao L, Crabb DM, Moser SA, Duffy LB, Glass JI, Paralanov V, Waites KB. 2011. Genotypic characterization of Ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresis. J Clin Microbiol. 49(9):3325–3328.
  • Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB. 2010. Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J Clin Microbiol. 48(8):2715–2723.
  • Xiao L, Paralanov V, Glass JI, Duffy LB, Robertson JA, Cassell GH, Chen Y, Waites KB. 2011. Extensive horizontal gene transfer in Ureaplasmas from humans questions the utility of serotyping for diagnostic purposes. J. Clin. Microbiol. 49(8):2818–2826.
  • Yi J, Yoon BH, Kim EC. 2005. Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR. Mol Cell Probes. 19(4):255–260.
  • Yoon BH, Romero R, Lim J-H, Shim S-S, Hong J-S, Shim J-Y, Jun JK. 2003. The clinical significance of detecting Ureaplas- ma Urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol. 189(4):919–924.
  • Zhang J, Kong Y, Feng Y, Huang J, Song T, Ruan Z, Song J, Jiang Y, Yu Y, Xie X. 2014a. Development of a multilocus sequence typing scheme for Ureaplasma. Eur J Clin Microbiol Infect Dis. 33(4):537–544.
  • Zhang J, Kong Y, Ruan Z, Huang J, Song T, Song J, Jiang Y, Yu Y, Xie X. 2014b. Correlation between Ureaplasma subgroup 2 and genitourinary tract disease outcomes revealed by an expanded multilocus sequence typing (eMLST) scheme. PLoS One. 9(8):e104347.
  • Zhang W, Wu Y, Yin W, Yu M. 2002. Study of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites. Chinese Med J. 115:1573–1575.
  • Zheng X, Teng LJ, Watson HL, Glass JI, Blanchard A, Cassell GH. 1995. Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation. Infect Immun. 63(3):891–898.
  • Zhou YH, Ma HX, Shi XX, Liu Y. 2018. Ureaplasma spp. in male infertility and its relationship with semen quality and seminal plasma components. J Microbiol Immunol Infect. 51(6):778–783.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.